id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0542-0008,FDA,FDA-2008-P-0542,FDA/CFSAN Response to Coburn & Coffman PLLC - Petition Denial,Other,PDN-Petition Denial,2009-12-09T05:00:00Z,2009,12,2009-12-09T05:00:00Z,,2013-07-27T23:01:55Z,,0,0,0900006480a67862
FDA-2008-P-0542-0003,FDA,FDA-2008-P-0542,"Attachment 11 - ""Toxicology of Rebaudioside A:A Review"" - [Coburn & Coffman PLLC - Citizen Petition] re FDA-2008-P-0542-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-10-29T04:00:00Z,2008,10,,,2009-01-30T03:21:07Z,,0,0,090000648073e5fc
FDA-2008-P-0542-0005,FDA,FDA-2008-P-0542,"Attachment 13 - ""Steviol Glycosides - Chemical and Technical Assessment"" - [Coburn & Coffman PLLC - Citizen Petition] re FDA-2008-P-0542-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-10-29T04:00:00Z,2008,10,,,2009-01-30T03:23:49Z,,0,0,090000648073e636
FDA-2008-P-0542-0002,FDA,FDA-2008-P-0542,Acknowledgement Letter to Coburn & Coffman PLLC,Other,ACK-Acknowledgement Letter,2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,,2024-11-07T21:55:37Z,,1,0,090000648073e7ed
FDA-2008-P-0542-0004,FDA,FDA-2008-P-0542,"Attachment 12 - USP Application Publication - ""Medicament for Treatment or Non-Insulin Dependent Diabetes Mellitus, Hypertension and/or Metabolic Syndrome"" - [Coburn & Coffman PLLC - Citizen Petition] re FDA-2008-P-0542-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-10-29T04:00:00Z,2008,10,,,2009-01-30T03:22:09Z,,0,0,090000648073e60f
FDA-2008-P-0542-0001,FDA,FDA-2008-P-0542,Coburn & Coffman PLLC - Citizen Petition,Other,CP-Citizen Petition,2008-10-14T04:00:00Z,2008,10,2008-10-14T04:00:00Z,,2024-11-07T21:57:02Z,,1,0,090000648073c56d